The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Rheumatic Disease Report Card 2022 Released: No A’s Given Overall; Oklahoma Ranks Most Improved

Rheumatic Disease Report Card 2022 Released: No A’s Given Overall; Oklahoma Ranks Most Improved

September 13, 2022 • By Vanessa Caceres

  • Tweet
  • Email
Print-Friendly Version / Save PDF

In honor of Rheumatic Disease Awareness Month, the ACR released a new Rheumatic Disease Report Card as part of its Simple Tasks public awareness campaign. The report card seeks to help answer the question, “How easy is it to live with rheumatic disease in my state?”

You Might Also Like
  • Maryland Gets an A; Most States Receive a C on ACR’s 1st Rheumatic Disease Report Card
  • Help Your Patients Live Well with Rheumatic Disease
  • Arizona Project Trains Rural Clinics to Triage & Refer Rheumatic Disease Cases
Explore This Issue
October 2022
Also By This Author
  • Advances in Rheumatology & Challenges that Remain Spotlighted in ACR Convergence 2021 Closing Session

First released in 2018, the report card has been updated to provide new scores to see how much states have improved. It considers such factors as access to care, affordability, and activity and lifestyle elements when providing each state with a score and corresponding letter grade.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

2022 RDAM Report CardThe access category considers number of residents per rheumatologist, the percentage of residents who lack insurance coverage, the strength of the state’s laws to limit prior authorization and the strength of the state’s legislation to limit insurers’ use of step therapy.

The affordability category awards states points on the basis of the presence of state legislation limiting insurer use of specialty tiers, the strength of the state’s laws promoting pharmacy benefit manager (PBM) transparency and the presence of state legislation preventing insurers from implementing copay accumulators.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The activity category looks at such factors as the prevalence of arthritis-attributable activity limitation among adults, the percentage of adults who are physically inactive and the prevalence of Centers for Disease Control and Prevention (CDC) funded arthritis intervention programs.

Each state received a numerical score and a letter grade in each area. The potential total score was 150 points. States then received an overall letter grade to reflect their score.

Which States Made the Grade?

No states received an overall grade of A. However, five states achieved a B, the highest grades awarded:

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE
  • New York (a score of 111 out of 150);
  • Virginia (106/150);
  • Maryland (105/150);
  • California (93/150); and
  • Illinois (92/150).

Most states received an overall grade of C or D (see map, above).

The state with the highest score in the 2018 report card was Maryland, followed by New York, Vermont, Colorado and Connecticut.

This year’s report card recognizes Oklahoma as the most improved state … . Its score went up by 31 points, & it moved from the lowest scoring state [in 2018] to a ranking of 20th place in 2022.

This year’s top scorer, New York, earned an A for access and was the only state to do so in that category. “The A in the access category was due to the strength of its state legislation to limit insurer use of prior authorization and step therapy, as well as its low ratio of people per rheumatologist,” says Jocelyn Givens, director of public relations and communications at the ACR. New York received a B for affordability and activity.

Pages: 1 2 3 | Single Page

Filed Under: American College of Rheumatology, From the College Tagged With: RDAM, Report Card, Rheumatic Disease Awareness MonthIssue: October 2022

You Might Also Like:
  • Maryland Gets an A; Most States Receive a C on ACR’s 1st Rheumatic Disease Report Card
  • Help Your Patients Live Well with Rheumatic Disease
  • Arizona Project Trains Rural Clinics to Triage & Refer Rheumatic Disease Cases
  • Texas Establishes Gold Card for Prior Authorization Exemption

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)